Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 3
1993 8
1994 5
1995 2
1996 7
1997 8
1998 6
1999 13
2000 13
2001 21
2002 18
2003 10
2004 13
2005 10
2006 16
2007 21
2008 28
2009 20
2010 16
2011 5
2012 16
2013 9
2014 15
2015 12
2016 8
2017 6
2018 3
2019 7
2020 8
2021 6
2022 9
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Results by year

Filters applied: . Clear all
Page 1
Cefditoren.
[No authors listed] [No authors listed] 2023 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000384 Free Books & Documents. Review.
Cefditoren is no longer marketed in the United States. Although no information is available on the use of cefditoren during breastfeeding, cephalosporins are generally not be expected to cause adverse effects in breastfed infants. Occasionally disruption of the infa …
Cefditoren is no longer marketed in the United States. Although no information is available on the use of cefditoren during br …
Interventions for bacterial folliculitis and boils (furuncles and carbuncles).
Lin HS, Lin PT, Tsai YS, Wang SH, Chi CC. Lin HS, et al. Cochrane Database Syst Rev. 2021 Feb 26;2(2):CD013099. doi: 10.1002/14651858.CD013099.pub2. Cochrane Database Syst Rev. 2021. PMID: 33634465 Free PMC article.
There may be an increased risk with cefadroxil compared with flucloxacillin after 10 days (6/327 versus 2/324, RR 2.97, 95% CI 0.60 to 14.62; 651 participants; 1 study; low-certainty evidence) and cefditoren pivoxil compared with cefaclor after 7 days (2/77 versus 0/73, RR …
There may be an increased risk with cefadroxil compared with flucloxacillin after 10 days (6/327 versus 2/324, RR 2.97, 95% CI 0.60 to 14.62 …
Cefditoren pivoxil.
Darkes MJ, Plosker GL. Darkes MJ, et al. Drugs. 2002;62(2):319-36; discussion 337-8. doi: 10.2165/00003495-200262020-00006. Drugs. 2002. PMID: 11817976 Review.
Cefditoren pivoxil is an orally absorbed prodrug that is rapidly hydrolysed by intestinal esterases to the microbiologically active cephalosporin cefditoren. ...Cefditoren penetrates rapidly into bronchopulmonary and tonsillar tissue as well as inflammatory a …
Cefditoren pivoxil is an orally absorbed prodrug that is rapidly hydrolysed by intestinal esterases to the microbiologically active c …
Cefditoren: a clinical overview.
Giuliano S, Acquasanta A, Martini L, Sbrana F, Flammini S, Tascini C. Giuliano S, et al. New Microbiol. 2023 Feb;46(1):9-17. New Microbiol. 2023. PMID: 36853812 Free article. Review.
Cefditoren is an oral third-generation cephalosporin with a large spectrum activity against Gram-negative and Gram-positive bacteria which are reported to be responsible for respiratory tract and skin and skin structure infections. In this work we reviewed the pharmacodyna …
Cefditoren is an oral third-generation cephalosporin with a large spectrum activity against Gram-negative and Gram-positive bacteria …
Cefditoren-induced hepatitis.
Martín Guerra JM, Moreta Rodríguez M. Martín Guerra JM, et al. Rev Esp Enferm Dig. 2022 Sep;114(9):563-564. doi: 10.17235/reed.2022.8801/2022. Rev Esp Enferm Dig. 2022. PMID: 35373567 Free article.
Cephalosporins for the treatment of uncomplicated pyelonephritis: A systematic review.
Zimmerman DE, Tomas M, Miller D, Tomcsanyi L, Signorella C, Montepara CA, Covvey JR, Guarascio AJ. Zimmerman DE, et al. J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1461-1471. doi: 10.1016/j.japh.2023.06.028. Epub 2023 Jul 4. J Am Pharm Assoc (2003). 2023. PMID: 37414282 Review.
Cephalosporins most used across the studies included cefazolin, cephalexin, cefuroxime, cefotaxime, cefdinir, cefditoren, and ceftriaxone. Outcomes assessed were diverse, including clinical or microbiological success and time to defervescence or symptom resolution. ...
Cephalosporins most used across the studies included cefazolin, cephalexin, cefuroxime, cefotaxime, cefdinir, cefditoren, and ceftria …
Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin.
Guay DR. Guay DR. Clin Ther. 2001 Dec;23(12):1924-37; discussion 1923. doi: 10.1016/s0149-2918(01)80147-8. Clin Ther. 2001. PMID: 11813929 Review.
Cefditoren is stable to hydrolysis by many common beta-lactamases. Cefditoren is rapidly absorbed (time to peak plasma concentration, approximately 2-3 hours) from the gastrointestinal tract and is almost completely eliminated via renal clearance of unchanged drug. …
Cefditoren is stable to hydrolysis by many common beta-lactamases. Cefditoren is rapidly absorbed (time to peak plasma concent …
Cefditoren, a new aminothiazolyl cephalosporin.
Balbisi EA. Balbisi EA. Pharmacotherapy. 2002 Oct;22(10):1278-93. doi: 10.1592/phco.22.15.1278.33481. Pharmacotherapy. 2002. PMID: 12389878 Review.
Cefditoren is also effective against methicillin-susceptible strains of Staphylococcus aureus. ...Moreover, cefditoren does not inhibit Pseudomonas aeruginosa or Bacteroides fragilis. ...
Cefditoren is also effective against methicillin-susceptible strains of Staphylococcus aureus. ...Moreover, cefditoren does no …
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
Biedenbach DJ, Jones RN. Biedenbach DJ, et al. Diagn Microbiol Infect Dis. 2009 Jun;64(2):202-12. doi: 10.1016/j.diagmicrobio.2009.01.017. Epub 2009 Mar 25. Diagn Microbiol Infect Dis. 2009. PMID: 19321284 Review.
Clinical trial data worldwide support the use of cefditoren for infections and species that have been approved by the US Food and Drug Administration (US-FDA). ...The potency of cefditoren (MIC(90), 0.5 microg/mL) was similar to that of amoxicillin/clavulanate and c …
Clinical trial data worldwide support the use of cefditoren for infections and species that have been approved by the US Food and Dru …
Spotlight on cefditoren pivoxil in bacterial infections.
Wellington K, Curran MP. Wellington K, et al. Treat Respir Med. 2005;4(2):149-52. doi: 10.2165/00151829-200504020-00012. Treat Respir Med. 2005. PMID: 15813670 Review.
Cefditoren pivoxil (Spectracef, Meiact) is a third-generation oral cephalosporin with a broad spectrum of activity against pathogens, including both Gram-positive and -negative bacteria, and is stable to hydrolysis by many common beta-lactamases. ...In clinical trials in a …
Cefditoren pivoxil (Spectracef, Meiact) is a third-generation oral cephalosporin with a broad spectrum of activity against pathogens, …
330 results